Disturbed Blood Flow Worsens Endothelial Dysfunction in Moderate-severe Chronic Obstructive Pulmonary Disease
Authors
Affiliations
The aims of this study were: (1) to test whether oscillatory shear stress further exacerbates endothelial dysfunction in patients with moderate-severe COPD, and (2) to test whether low flow oxygen administration improves endothelial function and is protective against oscillatory shear stress-induced endothelial dysfunction in patients with moderate-severe COPD. In 17 patients and 10 age-matched non-smoking control subjects we examined brachial artery flow-mediated dilation (FMD) and circulating microparticles before and after 20 minutes of experimentally-induced oscillatory shear stress. COPD patients performed this intervention a second time following a 20-minute wash in period of low flow supplemental oxygen to normalize arterial oxygen saturation. COPD patients had ~six-fold greater baseline retrograde shear rate (P < 0.05) and lower FMD (P < 0.05). The oscillatory shear stress intervention induced significant decreases in brachial artery FMD of all groups (P < 0.05). Oscillatory shear stress elevated circulating markers of endothelial cell apoptosis (CD31+/CD41b- microparticles) in COPD patients, but not age-matched controls. Supplemental oxygen administration abrogated the oscillatory shear stress-induced increase in CD31+/CD41b- microparticles, and improved FMD after accounting for the shear stress stimulus. We have demonstrated that acutely disturbed blood flow with increased retrograde shear stress further deteriorates the already impaired endothelial function with attendant endothelial apoptosis in patients with moderate-severe COPD.
Moradicheghamahi J, Goswami D Micromachines (Basel). 2025; 16(1).
PMID: 39858706 PMC: 11767820. DOI: 10.3390/mi16010051.
Zhang G, Yang J, Xing H, Yin H, Gu G Int J Gen Med. 2024; 17:1117-1125.
PMID: 38532846 PMC: 10964785. DOI: 10.2147/IJGM.S435417.
Pulmonary Vascular Dysfunctions in Cystic Fibrosis.
Amoakon J, Mylavarapu G, Amin R, Naren A Physiology (Bethesda). 2024; 39(4).
PMID: 38501963 PMC: 11368519. DOI: 10.1152/physiol.00024.2023.
Chalkias A Int J Mol Sci. 2023; 24(24).
PMID: 38139351 PMC: 10743945. DOI: 10.3390/ijms242417522.
Extracellular Vesicles' Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPD.
Di Gioia S, Daniello V, Conese M Int J Mol Sci. 2023; 24(1).
PMID: 36613669 PMC: 9820204. DOI: 10.3390/ijms24010228.